Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The main objective of the Atopic Dermatitis and Vaccinia Immunization Network (ADVN) is to
reduce the risk of the fatal reaction, eczema vaccinatum (EV), to the smallpox vaccination in
those with atopic dermatitis (AD). Since vaccination with live vaccinia virus (VV) in
individuals with AD increases the risk of EV, a yellow fever vaccine was chosen. The purpose
of this study is to determine the immune response to a yellow fever vaccine in adults with
AD.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)